KEAP1 and central nervous system cancer: In glioma models, KEAP1 knockout significantly enhances tumor cell ferroptosis resistance through NRF2–SLC7A11 axis activation [411], molecularly elucidating the tumor‐suppressive mechanisms of KEAP1.